Tianjin Red Sun Pharmaceutical Co., Ltd. announces the closure of its special account for raised funds. This follows the completion of its initial public offering and the subsequent allocation of remaining funds. The closure aligns with regulatory requirements and concludes the management of these funds.
Summary generated by AI · Always verify with source document
Tianjin Red Sun Pharmaceutical Co., Ltd.
Securities Code: 300026
Securities Abbreviation: Red Sun Pharmaceutical
Announcement No.: 2026-051
Announcement on the Closure of Special Account for Raised Funds
The Company and all members of the Board of Directors guarantee the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.